It’s taken decades, but researchers are finally starting to look at endometriosis differently.

For years, people with endometriosis have been stuck in a frustrating cycle. The pain can be severe, sometimes completely debilitating, yet they're told it's just part of having a period. They go back to the doctor, are told to try birth control, perhaps get sent for an ultrasound and eventually see a specialist, if they’re lucky. Still, the years can tick by before anyone finally puts the pieces together.

In the U.S., more than 6.5 million women have endometriosis, yet it remains notoriously difficult to diagnose and treat. Diagnosis has traditionally relied heavily on laparoscopy, which is an invasive surgical procedure, and many of the symptoms can look like other conditions. It's not hard to see how someone can spend years wondering what on earth is actually going on.

But 2026 is starting to look a little different. Researchers across the U.S. are exploring blood tests, at-home testing, genetic risk factors and new ways of understanding why endometriosis causes pain in the first place. The National Institutes of Health has also put millions of dollars behind the search for non-invasive ways to diagnose the disease.

None of this happened overnight. Behind these research projects is a much bigger story about patients who spent years saying, “this isn't normal,” and advocates who refused to stop pushing for endometriosis to receive more attention, more research funding and ultimately, better care.

Why Has Endometriosis Been So Difficult to Diagnose?

Endometriosis happens when tissue similar to the lining of the uterus grows elsewhere in the body. It can cause pelvic pain, painful periods, pain during sex, painful bowel movements or urination, heavy bleeding, fatigue, and fertility problems. Some people have relatively few symptoms, while others find that pain and other symptoms affect their work, relationships, exercise, sleep, and everyday life.

One of the biggest problems has been the lack of a simple and non-invasive way to confirm the condition. For many years, a definitive diagnosis was closely associated with laparoscopy, a surgical procedure that allows doctors to look inside the pelvis. While laparoscopy still has an important role in endometriosis care, surgery is a big step to take when someone is simply trying to understand why they're experiencing severe pain or other symptoms.

There are practical barriers too. Surgery requires anesthesia and recovery time, and access to specialists can vary considerably depending on where someone lives, their insurance coverage and other circumstances. On top of that, endometriosis can look different from person to person, and symptoms can overlap with conditions such as irritable bowel syndrome and other pelvic disorders.

That combination can make the diagnostic process incredibly frustrating. Someone knows something isn't right, keeps going back for help and can still find themselves without an answer years later.

There has been some progress. New guidance from the American College of Obstetricians and Gynecologists recognizes that endometriosis can be diagnosed based on symptoms and clinical evaluation rather than requiring surgery before treatment can begin, while imaging can also play an important role. Although laparoscopy remains useful, it’s no longer the only route doctors can consider when evaluating someone with suspected endometriosis.

What’s promising is that researchers are still looking for ways to make the process easier, and that has led to some new approaches in 2026.

The NIH Is Putting Serious Money Behind Better Diagnosis

The U.S. government isn't just talking about the need for better endometriosis diagnostics. In 2024, the National Institutes of Health launched the RADx Tech ACT ENDO Challenge, a $3 million competition designed to accelerate the development of non-invasive technologies that could make endometriosis diagnosis faster, safer, and more accessible. The challenge has now wrapped up, and the results give us a pretty good idea of where some of the research is heading.

The first-place prize of $600,000 went to Endometrics, which is developing a diagnostic approach using menstrual fluid collected at home. The Feinstein Institutes for Medical Research at Northwell Health took second place with another menstrual-fluid approach, while 3CPM Company won third place for a technology that measures electrical activity in the digestive system. Washington University in St. Louis was the runner-up with technology designed to measure uterine peristalsis, the muscle contractions that occur in the uterus during the menstrual cycle.

The four winning approaches are also very different from one another. Researchers are looking at menstrual fluid, electrical signals from the body, and uterine activity, rather than relying on invasive procedures to identify the disease. The technologies are still being developed and haven't yet become routine diagnostic tests, so we're not at the point where someone can simply order one at their doctor's office. But the research is moving towards something patients have been waiting for: a way to identify endometriosis without having to go through an invasive procedure first.

For people who have spent years navigating appointments, referrals, and uncertainty, this could eventually make a very real difference.

Could an At-Home Test Change the Diagnostic Journey?

One of the more unusual projects is coming from the University of Cincinnati, where researcher Katie Burns, PhD, is working on a potential at-home diagnostic test that uses menstrual fluid to look for changes in white blood cells associated with endometriosis.

Burns also has a personal connection to this research, as she has endometriosis herself. She experienced severe symptoms as a child, followed by years of misdiagnosis and multiple surgeries. Those experiences helped shape the questions she is now investigating in the laboratory.

Her team is studying the immune response involved in endometriosis and whether white blood cells found in menstrual fluid could act as useful biomarkers. The idea is that, rather than requiring someone to undergo an invasive procedure simply to investigate whether endometriosis could be behind their symptoms, a sample collected at home might eventually provide doctors with information that helps identify the condition.

We're not there yet. The test is still being developed and isn't something you can currently pick up at a pharmacy or request as a routine diagnostic test. It will need much more research before we know how well it works across different groups of patients and whether it can become a reliable clinical tool.

The concept could make the diagnostic process much easier if it eventually proves to work, particularly for people who struggle to access specialist care.

Could a Blood Test Help Diagnose Endometriosis?

Menstrual fluid isn't the only thing researchers are investigating. ARPA-H, the U.S. government's Advanced Research Projects Agency for Health, awarded up to $10 million to Aspira Women's Health in 2024 to develop a non-invasive blood test for endometriosis. The project aimed to identify biological markers in the blood that could help detect the disease without surgery. The program was later terminated in June 2025 after Aspira did not meet the requirements of its third milestone, although the company disputed that assessment.

Researchers are also interested in whether blood tests could eventually tell us more than whether someone has endometriosis. They could potentially help researchers understand how the disease is developing and why it affects people so differently.

That matters because endometriosis can look very different from one person to another. Some people experience severe pelvic pain, while others may have fertility problems or symptoms affecting the bowel or bladder. Treatments don't work the same way for everyone either.

A reliable blood test could therefore be useful for more than simply confirming a diagnosis. In the future, researchers hope that biological markers could help identify different forms of the disease and lead to more personalized treatment.

We're still a long way from that, but researchers are looking at endometriosis in ways that could eventually change how the disease is diagnosed and treated.

Researchers Are Getting a Clearer Picture of the Genetics

Diagnosis isn't the only area where researchers are making progress. In 2026, Yale researchers and an international team of scientists published the largest genetic study of endometriosis to date, looking at data from more than 1.4 million women, including more than 105,000 with endometriosis.

They identified 80 regions of the genome linked to the disease, including 37 that hadn't been identified before. The findings point to genetic links involving inflammation, hormone regulation and how tissue changes in the body. They also found connections with adenomyosis and potential targets that could be explored for future treatments.

This doesn't mean there's now a genetic test for endometriosis. There isn't. But the research does give scientists a much better understanding of the biology behind the disease and gives them more clues about where to look for new treatments and diagnostic tools.

Research like this can take years to translate into something patients actually use, but understanding what is happening at a genetic level could eventually help researchers develop better ways to diagnose and treat endometriosis.

Why Can Endometriosis Pain Be So Different?

One of the frustrating things about endometriosis is that the amount of disease doesn't always match the amount of pain someone experiences. Someone with relatively limited endometriosis can have severe, life-disrupting pain, while someone with more extensive disease may have far fewer symptoms.

Researchers are starting to look more closely at why that happens. In 2026, Yale researchers compared tissue from people with painful and asymptomatic endometriosis and found almost 900 genes that were expressed differently between the two groups. Many of these differences were linked to inflammation, and one molecule called IL16 was particularly associated with pain severity.

The research doesn't explain endometriosis pain completely, but it gives scientists more clues about what could be driving it. If certain biological pathways are linked to more severe pain, they could eventually become targets for treatments designed specifically around those processes.

That matters a great deal for people living with endometriosis. Pain can have a huge impact on everyday life, and understanding why some people experience much more of it could be an important step towards better treatment.

So Where Do Patients Fit Into All Of This?

People with endometriosis were talking about these problems long before there were large genetic studies, advanced biomarkers, or millions of dollars going into non-invasive diagnostic research. They were describing what it was actually like to live with severe pain, fatigue, digestive symptoms, fertility problems, and years of uncertainty. When they weren't being heard, they kept pushing the conversation forward.

Patient organizations and advocates have spent years pushing those experiences into conversations about women's health, research funding, and healthcare policy. The Endometriosis Foundation of America, for example, says its work with the bipartisan Congressional Endometriosis Caucus helped contribute to a doubling of NIH funding for endometriosis research in 2020.

That doesn't mean advocacy directly caused the breakthroughs we're seeing in 2026. Many of these studies have been years in the making, and research rarely follows a simple path from funding to discovery. What advocacy can do is make an overlooked condition harder to ignore. It highlights the long waits for diagnosis, gives patients a voice in research, and encourages policymakers and researchers to pay more attention to the areas where better answers are needed. For endometriosis, that pressure has been building for years, and the research landscape is finally starting to look very different.

Patients Aren't Just Raising Their Voices, They're Helping Create the Data

There is another part of the story that doesn't always get as much attention. Researchers are increasingly using information collected directly from patients because endometriosis can look very different from one person to another, and symptoms can change throughout the menstrual cycle.

The Phendo Project, developed by researchers at Columbia University, uses a free mobile app to collect information about endometriosis symptoms and experiences. More than 22,000 people have used the app to track their symptoms and contribute health information to research.

That gives researchers a much bigger picture than a single doctor's appointment can provide. Someone might have manageable symptoms one week and debilitating pain the next, or notice that certain symptoms appear at particular points in their cycle. They might also be dealing with fatigue, bowel or bladder problems, or mood changes alongside pelvic pain.

Because doctor's appointments can be short, these patterns can be difficult to spot, particularly when symptoms aren't the same every day. Patient-generated data gives researchers another way to understand what endometriosis actually looks like over time. It also gives people with the condition a more active role in research, helping researchers understand the questions and experiences that matter in everyday life.

But Let's Not Get Ahead of Ourselves

With all the talk about blood tests, at-home testing, and genetic discoveries, it would be easy to assume that diagnosing endometriosis is about to become dramatically easier. Unfortunately, we're not quite there yet.

There is currently no FDA-approved non-invasive test that can diagnose endometriosis in routine clinical care. Several promising approaches are being investigated, but many are still in development or have only been tested in relatively small groups. A test can look promising in an early study and still need years of research before we know whether it works reliably across different populations, stages of disease and the many ways endometriosis can present.

It also needs to actually help patients. Finding a biological marker is one thing. Developing a test that doctors can rely on, patients can access and healthcare systems can use effectively is another. This can feel frustratingly slow to people who’ve spent years waiting for answers. But making sure a new test genuinely works is just as important as developing it in the first place.

So What Does 2026 Actually Tell Us?

The biggest story coming out of 2026 isn't one particular blood test, genetic discovery, or piece of technology. It's how many different areas of endometriosis research are moving forward at the same time.

Researchers are looking at genetics, the immune system, menstrual fluid, blood biomarkers and the reasons pain can vary so dramatically from one person to another. They're also exploring new imaging techniques and digital tools that could eventually make diagnosis easier and more accessible.

At the same time, patients and advocates continue to push for more research funding, better access to care, and greater recognition of what it's actually like to live with endometriosis. The condition hasn't been solved. There is still no cure, diagnosis can still take far too long, and many people are still struggling to get the care they need.

What has changed is the amount of attention being given to the disease and the number of different questions researchers are now trying to answer. Those questions are being investigated from several different angles, with more researchers, funding and technology behind them.

For years, people with endometriosis kept saying that something wasn't right. Patient advocacy didn't create every breakthrough we're seeing in 2026, and research rarely moves in a straight line, but those voices have helped keep endometriosis in the spotlight and push for greater investment.

Now researchers are looking for answers in places we weren't looking before, and that could eventually change what diagnosis and treatment look like for the millions of people living with the disease.

‍